http://www.raredr.com/news/woodcock-duchenne
Janet Woodcock - Duchenne Drug Review and the Patients' Input

Janet Woodcock, MD




Janet Woodcock, MD,  Director of the Center for Drug Evaluation and Research (CDER) at the Food and Drug Administration (FDA) talks about the important role that the Duchenne advocacy groups played in the FDA's review of eteplirsen.
Printer Printing...
$content$